IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.790
-0.030 (-1.65%)
At close: Dec 5, 2025, 4:00 PM EST
1.770
-0.020 (-1.12%)
After-hours: Dec 5, 2025, 5:47 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $8.20 million as of December 5, 2025. Its market cap has decreased by -64.30% in one year.
Market Cap
8.20M
Enterprise Value
470.88K
1-Year Change
-64.30%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $8.20M, a decrease of -95.63%. That is a compound annual growth rate of -51.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.20M | -56.00% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |